Market Tracker

02/24 5:16pm ET

Apricus Biosciences Inc (NASDAQ:APRI)

3.07
Delayed Data
As of Feb 24
 -0.0116 / -0.38%
Today’s Change
1.10
Today|||52-Week Range
15.40
+136.03%
Year-to-Date
No recent news for Apricus Biosciences Inc.

Today’s Trading

Previous close3.08
Today’s open3.09
Day’s range2.97 - 3.09
Volume119,624
Average volume (3 months)948,930
Market cap$23.8M
Dividend yield--
Data as of 3:59pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+30.45%
Earnings growth (this year)+60.66%
Earnings growth (next 5 years)--
Revenue growth (last year)-47.74%
P/E ratioNM
Price/Sales10.17
Price/Book--

Competitors

 Today’s
change
Today’s
% change
VICLVical Inc+0.02+0.78%
ABIOARCA Biopharma Inc+0.03+0.98%
AVIRAviragen Therapeutic...-0.02-2.40%
CLRBCellectar Bioscience...-0.06-2.73%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$4.8M
Annual profit (last year)-$19.0M
Net profit margin-393.12%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer, CAO, Secretary &
Director
Richard W. Pascoe
Chief Business Officer &
Senior Vice President
Neil C. Morton
Corporate headquarters
San Diego, California

Forecasts